PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'BP - A Beneficência Portuguesa de São Paulo - São Paulo (SP), Brasil.\', \'Brazilian Research in Intensive Care Network (BRICNet) - São Paulo (SP), Brasil.\', \'Instituto de Pesquisa, HCor-Hospital do Coração - São Paulo (SP), Brasil.\', \'Hospital Moinhos de Vento - Porto Alegre (RS), Brasil.\', \'Organização de Pesquisa Acadêmica, Hospital Israelita Albert Einstein - São Paulo (SP), Brasil.\', \'Hospital Sírio-Libanês - São Paulo (SP), Brasil.\', \'Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, Estados Unidos.\', \'Brazilian Clinical Research Institute - São Paulo (SP), Brasil.\', \'Centro Internacional de Pesquisa, Hospital Alemão Oswaldo Cruz - São Paulo (SP), Brasil.\', \'Fleury Medicina e Laboratórios - São Paulo (SP), Brasil.\', \'Santa Casa de Porto Alegre - Porto Alegre (RS), Brasil.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0103-507X202000030033710.5935/0103-507X.20200060
?:doi
?:hasPublicationType
?:journal
  • Revista Brasileira de terapia intensiva
is ?:pmid of
?:pmid
?:pmid
  • 32965395
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.347
?:rankingScore_hIndex
  • 11
is ?:relation_isRelatedTo_publication of
?:title
  • Rationale and design of the \'Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled\' trial (TOCIBRAS).
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32965395>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32965395>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all